Collaborative Antiviral Study Group

The Collaborative Antiviral Study Group (CASG) is a group of medical researchers and clinicians who work together to study and develop treatments for viral infections, especially hepatitis B and C. They design and conduct clinical trials to test new medications, gather data on how well they work, and ensure safety. Their goal is to improve treatment options for patients worldwide through collaborative research. By sharing expertise and resources, CASG accelerates the discovery and approval of effective antiviral therapies, ultimately aiming to reduce the health impact of viral diseases.